4/A

MAIN DOCUMENT DESCRIPTION

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: March 10, 2005
Period of Report: May 27, 2004
Accession Number: 0001209191-05-014766

View Document ↗ View on SEC.gov ↗